Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis

doi:10.3748/wjg.v23.i17.3133

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8249)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

571

WORD

293

HTML

3852

Figures (1-5)

410

Tables (1-6)

338

Sum=5464

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1080

Download

1702

Sum=2782

May 7, 2017 (publication date) through Apr 24, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2017; 23(17): 3133-3141
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3133

Table 2 The pathological grade of hepatitis

Grade	Description	Criteria
G0	No activity	No lobular inflammation and necrosis
G1	Minimal activity	Minimal, occasional spotty necrosis
G2	Mild activity	Mild, little hepatocellular damage
G3	Moderate activity	Moderate, noticeable hepatocellular change
G4	Severe activity	Severe, prominent diffuse hepatocellular damage

Citation: Li XM, Chen Z, Xiao EH, Shang QL, Ma C. Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis. World J Gastroenterol 2017; 23(17): 3133-3141
URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3133.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3133